Which Is Better for Anxiety: Lorazepam or Hydroxyzine?

Neither lorazepam nor hydroxyzine is categorically better for anxiety. They belong to entirely different drug classes, work through different brain pathways, and carry different risks, so the right choice depends on your situation: how quickly you need relief, how long you’ll be taking the medication, whether you have a history of substance use, and what other health conditions you’re dealing with. Lorazepam is a benzodiazepine that acts fast and hits hard but comes with real dependence risk. Hydroxyzine is an antihistamine with no abuse potential but a more modest anxiolytic punch and its own set of concerns, including a cardiac safety signal that many people don’t hear about.

How Each Drug Actually Works

Lorazepam enhances the activity of a neurotransmitter called GABA, which is your nervous system’s main brake pedal. When lorazepam binds to GABA receptors in the brain, it amplifies GABA’s calming signal, quickly dialing down the electrical chatter that drives anxiety. That mechanism is powerful but comes with a catch: the same receptor pathway connects to the brain’s reward circuitry. Research has shown that benzodiazepines, acting through specific GABA-A receptor subtypes, can activate midbrain dopamine neurons and effectively hijack the mesolimbic reward system, which is the same circuitry involved in addiction to other substances.¹ That’s why lorazepam works so well for acute anxiety and why it can be so hard to stop.

Hydroxyzine takes a completely different route. It’s a first-generation antihistamine, the same general category as diphenhydramine (the active ingredient in Benadryl), but it has stronger anti-anxiety properties. It blocks histamine H1 receptors, which produces sedation, and it also has some effect on serotonin receptors. The anti-anxiety action is real but subtler than what a benzodiazepine delivers. Hydroxyzine doesn’t touch the GABA system at all, which means it doesn’t produce the euphoria or the neurological dependence that benzodiazepines can. That trade-off is at the heart of why these two drugs occupy such different spaces in clinical practice.

How They Compare for Sedation

Both drugs make you drowsy, but not in the same way or for the same duration. In a controlled double-blind trial comparing intramuscular lorazepam, hydroxyzine, and placebo as surgical premedicants, patients who received either drug were significantly more sedated than placebo patients within 60 minutes of injection. However, lorazepam’s sedative effect lasted longer than hydroxyzine’s.² That same study found that lorazepam-treated patients were consistently less able to recall events that happened after the injection compared to those given hydroxyzine or placebo. In other words, lorazepam doesn’t just sedate you more deeply; it clouds your memory of the sedated period in a way hydroxyzine doesn’t.

That memory effect matters practically. If you take lorazepam for a panic attack in the middle of the day, you may feel calmer, but you may also have hazy recall of conversations, decisions, or events that happened while the drug was active. Hydroxyzine sedation feels more like being very sleepy without the same amnestic quality. For some people, particularly those who need to remain somewhat functional, that’s a meaningful distinction.

Driving, Work, and Daily Functioning

One of the most practical questions about any anxiety medication is whether you can still do your job and drive your car while taking it. Lorazepam poses real problems here. A study that tested actual car handling ability alongside psychomotor tasks found that lorazepam produced significant impairment of driving performance and measurably reduced subjective alertness. The drug’s pronounced sedative activity also showed up in verbal reports of side effects and in early-morning sedation scores, meaning the hangover extends into the next day.³

Hydroxyzine also causes drowsiness, especially at higher doses, and it can slow reaction times. But because the sedation tends to be shorter-lived and doesn’t carry the same depth of cognitive impairment, many clinicians consider it less disruptive to daily activities. Neither drug is ideal if you need to be sharp, but lorazepam is notably worse for tasks that require coordination and alertness. If you’re taking either medication, you should know how it affects you personally before getting behind the wheel.

The Dependence Question

This is where the two drugs diverge most dramatically. Lorazepam, like all benzodiazepines, can produce physical dependence in as little as a few weeks of regular use. Your brain adapts to the constant GABA enhancement, and when the drug is removed, the nervous system rebounds with heightened excitability. Withdrawal symptoms can include rebound anxiety that’s worse than the original problem, insomnia, irritability, tremor, and in severe cases, seizures. The connection between benzodiazepines and the brain’s reward pathways means that psychological dependence can develop alongside the physical kind.¹

Hydroxyzine doesn’t produce physical dependence. You can stop taking it without a taper, and there’s no recognized withdrawal syndrome. That’s a major reason why hydroxyzine has become increasingly popular as a first-line option for anxiety, especially in patients who have a history of substance use disorders or who need something they can take regularly without building tolerance. It’s also why many emergency departments and psychiatric facilities have shifted toward hydroxyzine when they need to calm an agitated or anxious patient without introducing an addictive substance.

That said, the absence of dependence risk doesn’t make hydroxyzine harmless. Some people find the drowsiness so heavy that they effectively can’t function on it, and others find that it simply doesn’t control their anxiety well enough, which can lead to a different kind of problem: undertreated anxiety that interferes with daily life.

Coming Off Lorazepam and the Role Hydroxyzine Plays

Interestingly, hydroxyzine has been studied not just as an alternative to lorazepam but as a tool for getting off it. A controlled study comparing six different methods of lorazepam withdrawal, including hydroxyzine versus placebo, found that progressive tapering was preferable to abrupt discontinuation: patients who tapered gradually had fewer dropouts and rated the process more favorably.⁴ Anxiety levels decreased significantly in both the progressive and abrupt groups, but sleep quality and withdrawal symptoms between the first and fourth weeks improved only in the abrupt withdrawal group. That’s a somewhat counterintuitive finding: abrupt stoppers had a rougher start but saw faster improvement in sleep and withdrawal symptoms within the first month.

The takeaway for anyone currently on lorazepam who wants to switch to something without dependence potential is that the transition needs to be managed carefully, ideally with a prescriber who has experience with benzodiazepine tapers. Hydroxyzine can serve as a bridge during this process, helping to manage the rebound anxiety that comes when the benzodiazepine is reduced, but it won’t prevent all withdrawal symptoms because it works on an entirely different receptor system.

Older Adults and the Beers Criteria

If you’re over 65 or caring for someone who is, the calculus shifts further away from lorazepam. The American Geriatrics Society maintains the Beers Criteria, an explicit list of medications considered potentially inappropriate for older adults in most circumstances.⁵ Benzodiazepines as a class, including lorazepam, are on that list. The reasons are straightforward: older adults metabolize these drugs more slowly, are more sensitive to their sedative effects, and face substantially higher risks of falls, hip fractures, cognitive impairment, and delirium when taking them.

Hydroxyzine isn’t without concerns in older adults either. First-generation antihistamines have anticholinergic properties, which can cause dry mouth, constipation, urinary retention, and confusion in elderly patients, and these effects are also flagged in the Beers Criteria. So neither drug is a great long-term choice for older adults, but the risks associated with lorazepam in this population, particularly falls and cognitive decline, are generally considered more serious and more immediate than those of hydroxyzine.

A Cardiac Safety Signal Worth Knowing About

Here’s something that doesn’t get enough attention in the lorazepam-versus-hydroxyzine conversation. A pharmacovigilance study of the FDA’s Adverse Event Reporting System found that among anxiolytic drugs, hydroxyzine carried the highest risk of Torsade de Pointes, a dangerous type of abnormal heart rhythm that can lead to sudden cardiac arrest.⁶ This was already a known safety signal, and the study confirmed it. This risk is highest at higher doses and in people who already have a prolonged QT interval on their ECG, who are taking other QT-prolonging medications, or who have electrolyte imbalances.

For most healthy people taking hydroxyzine at standard doses (25 to 50 mg), this risk is very small. But it’s not zero, and it changes the conversation for anyone with heart disease, a known long QT syndrome, or who takes multiple medications that can affect heart rhythm. Lorazepam does not carry the same cardiac signal. If you have cardiac risk factors and your prescriber is choosing between these two drugs, that distinction could matter more than the sedation profile or the dependence question.

When the Anxiety Is Severe or Acute

For a genuine psychiatric crisis, the kind of anxiety where your heart is pounding, your thoughts are racing, and you feel like something terrible is about to happen, lorazepam works faster and more reliably. Its onset of action is roughly 15 to 30 minutes when taken by mouth and even faster when given by injection. The relief is tangible and dramatic, which is exactly why emergency departments have relied on benzodiazepines for decades.

Hydroxyzine also works fairly quickly, often within 15 to 30 minutes for oral dosing, but the ceiling on its anxiolytic effect is lower. For mild to moderate anxiety, that ceiling is often sufficient. For a full-blown panic attack or acute crisis, some patients find hydroxyzine underwhelming. That’s consistent with the surgical premedication study mentioned earlier, where baseline anxiety levels were too low to detect differences in anxiolytic effect between the drugs.² We don’t have great head-to-head data in high-anxiety populations, which is a frustrating gap in the research.

The practical pattern many clinicians follow is to prescribe hydroxyzine for daily or as-needed use in generalized anxiety and to reserve lorazepam for breakthrough panic or short-term use during a crisis period when other treatments are being established. That approach tries to capture the benefits of both: the safety and tolerability of hydroxyzine for routine management, with lorazepam available as a rescue medication for moments when the milder drug isn’t enough.

What Neither Drug Does Well

It’s worth stepping back and noting that neither lorazepam nor hydroxyzine is considered a first-line long-term treatment for most anxiety disorders. Current treatment guidelines for generalized anxiety disorder, social anxiety disorder, and panic disorder generally recommend SSRIs or SNRIs as first-line pharmacotherapy, sometimes combined with cognitive behavioral therapy. Both lorazepam and hydroxyzine sit in a different part of the treatment toolkit: they’re adjuncts, bridging agents, or alternatives for people who can’t tolerate or don’t respond to the standard options.

Lorazepam is effective but carries too much baggage for chronic daily use. Hydroxyzine is safe for long-term use but doesn’t have the robust evidence base that SSRIs and SNRIs do for sustained anxiety reduction. If you’re looking for something to take every day for months or years, both drugs are stopgap measures, not the main treatment. Having that context helps frame the comparison: you’re usually choosing between them for a specific clinical moment or a specific patient profile, not picking a lifelong medication.

Why Your Prescriber Chooses One Over the Other

In practice, the choice between lorazepam and hydroxyzine often comes down to a handful of patient-specific factors rather than which drug is objectively “stronger” or “better.” A prescriber weighing the two will typically consider:

Substance use history: Any past or current problem with alcohol, benzodiazepines, or opioids pushes strongly toward hydroxyzine. Lorazepam’s reward-system activation makes it a risky choice for people in recovery.
Severity of episodes: If the anxiety is severe and episodic, like panic attacks, lorazepam’s potency and rapid relief carry more weight. For lower-grade but persistent generalized anxiety, hydroxyzine often does the job.
Duration of use: Anything expected to last more than a few weeks favors hydroxyzine. Lorazepam’s dependence risk rises with every week of regular use.
Age: Patients over 65 are generally steered away from lorazepam due to fall risk and cognitive concerns, though hydroxyzine’s anticholinergic effects also warrant caution.
Cardiac history: Known QT prolongation or use of other QT-prolonging drugs makes hydroxyzine less appealing, and lorazepam becomes the safer cardiac option.
Need to function: If you need to work, drive, or care for dependents while managing anxiety, hydroxyzine’s lighter cognitive footprint gives it an edge over lorazepam’s deeper impairment.

No single factor usually determines the choice in isolation. A 30-year-old with panic disorder and no substance use history might reasonably start with hydroxyzine for daily management and have a small supply of lorazepam for emergencies. A 70-year-old with generalized anxiety and a cardiac history might be better served by neither of these drugs and instead be started on an SSRI with careful monitoring. The conversation is always more nuanced than “which one is better,” and the honest answer is that these two medications are solving slightly different problems even when they’re both prescribed under the banner of “anxiety treatment.”